On November 14, the Food and Drug Administration (FDA) announced new action to ban flavored e-cigarettes (e-cigs) at convenience stores.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
Last week, the Food and Drug Administration (FDA) announced a series of critical enforcement actions related to the sale and marketing of e-cigarettes to children and young adults. With the use of e-cigarettes among youth growing at an alarming rate in recent years, the agency has taken record actions to address this challenge and protect youth from the dangers of tobacco products through its Youth Tobacco Prevention Plan.
The findings from the National Youth Tobacco Survey (NYTS) show decreases in the use of cigarettes, cigars, smokeless tobacco, pipes, and bidis, and saw an increase in e-cigarette use from 2011 to 2017.
On January 23, a congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine was published on the health effects of e-cigarettes. This report is one of the most comprehensive on e-cigarettes to-date examining over 800 peer-reviewed scientific studies.